Cibiyar R&D

labarai

Cibiyar R&D

Cibiyar R&D

Don haɓaka ikon bincike da haɓakawa a cikin
masana'antar harhada magunguna, kamfaninmu yana alfaharin sanar da gina sabon tushe na samarwa. Tushen samar da kayan aikin ya ƙunshi adadin mu 150, tare da zuba hannun jari na Yuan 800,000. Kuma ya gina murabba'in murabba'in mita 5500 na cibiyar R&D, an sanya shi cikin aiki.

Kafa cibiyar R&D alama ce ta ci gaba mai mahimmanci a cikin ƙarfin binciken kimiyya na kamfaninmu a fannin likitanci. A halin yanzu, muna da babban matakin bincike da ƙungiyar haɓaka wanda ya ƙunshi ƙwararrun ma'aikatan 150 da fasaha. An sadaukar da su ga bincike da samar da jerin nucleoside monomers, ADC payloads, linker key intermediates, Building Block al'ada kira, kananan kwayoyin ayyuka CDMO, da sauransu.

Burinmu na ƙarshe shine don taimakawa hanzarta ƙaddamar da sabbin magunguna da haɓaka ingancin rayuwa ga marasa lafiya a duk duniya. Ta hanyar ci gaba da haɓaka sabbin fasahohi da ayyukan samar da magunguna na kore, za mu sami damar samar da sabis na CMC na tsayawa ɗaya ga kamfanonin harhada magunguna na cikin gida da na waje, tare da taimakawa kowane mataki na rayuwar miyagun ƙwayoyi daga haɓakawa zuwa aikace-aikace.

Mun fahimci cewa farashin-tasiri yana da mahimmanci ga abokan cinikinmu, wanda shine dalilin da ya sa muke amfani da hanyoyin samar da dorewa da inganci kamar ci gaba da halayen halayen da haɓakar enzymatic don rage farashin da fitar da ci gaba mai dorewa a cikin umarni. Ƙaddamar da mu ga inganci, ƙirƙira, da dorewa ya keɓe mu a matsayin jagora a cikin masana'antar harhada magunguna da kuma babban abokin tarayya a cikin neman duniya don ingantattun sakamakon kiwon lafiya.


Lokacin aikawa: Janairu-28-2023